Latest news
Apogee Therapeutics 2Q 2026: Net loss $85.9M, First half loss $160M — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 12:01:01 GMTApogee Therapeutics reports Q2 2026 results; cash and marketable securities $1.3B, net loss $85.9M - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMTApogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 11:00:00 GMTApogee Therapeutics (APGE) CMO trades stock under 10b5-1 plan - Stock TitanStock Titan · Sat, 08 Aug 2026 02:12:22 GMTDimensional Fund Advisors LP Has $35.67 Million Stock Position in Apogee Enterprises, Inc. $APOG - MarketBeatMarketBeat · Wed, 05 Aug 2026 10:18:59 GMTAbbVie (NYSE: ABBV) boosts Q2 profit, plans $10.9B Apogee acquisition - Stock TitanStock Titan · Fri, 31 Jul 2026 11:51:57 GMTAbbVie Reports Second-Quarter 2026 Financial Results - TradingViewTradingView · Fri, 31 Jul 2026 11:47:00 GMTAbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates - ReutersReuters · Fri, 31 Jul 2026 07:00:00 GMT